Current treatments for non-small cell lung cancer

Area of Science:

• Oncology
• Pulmonology
• Clinical Medicine

Background:

• Lung cancer, particularly non-small cell lung cancer (NSCLC), has high mortality rates despite diagnostic and therapeutic advancements.
• NSCLC represents the predominant histologic type of lung cancer encountered in clinical practice.

Purpose of the Study:

• To provide a comprehensive review of current diagnostic methods for NSCLC.
• To summarize established and emerging therapeutic strategies for NSCLC management.
• To serve as a clinical guide for healthcare professionals treating NSCLC patients.

Main Methods:

• Literature review of diagnostic techniques in NSCLC.
• Synthesis of data on various treatment modalities for NSCLC.
• Analysis of current clinical and preclinical research in NSCLC therapy.

Main Results:

• Current diagnostic approaches for NSCLC are detailed.
• A spectrum of therapies including chemotherapy, chemoradiotherapy, targeted therapy, antiangiogenic therapy, immunotherapy, and combination therapy are discussed.
• The review highlights the importance of multidisciplinary approaches in NSCLC treatment.

Conclusions:

• Despite progress, high mortality persists in NSCLC, underscoring the need for effective strategies.
• Comprehensive understanding of diagnostic and therapeutic options is crucial for improving patient outcomes.
• Continued research into novel treatments and diagnostic tools is essential for combating NSCLC.